United States Biotechnology & Medical Research

CNS Pharmaceuticals Inc (CNSP)

Track

Track

CNS Pharmaceuticals Inc. has recorded no insider trading activity within the last three months. The most recent transactions occurred on May 18, 2026, involving two separate buy orders. Prior to this period, historical data shows various acquisition patterns by company leadership, though no market movements have been reported since that spring date.
Ticker: CNSP Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for CNS Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Fisher Michal Non-Executive Director
Transaction date
Purchase
Price
155.81
Quantity 42,290 -5.1%
Value US$1,672,331
3.2
Charles Faith L. Non-Executive Director
Transaction date
Purchase
Price
60.63
Quantity 264 -20.3%
Value US$2,013,563
2.3
Downs Christopher Chief Financial Officer Officer
Transaction date
Purchase
Price
416.48
Quantity 19,380 -3.4%
Value US$4,170,183
Evans Carl Anthony Non-Executive Director
Transaction date
Purchase
Price
0.30
Quantity 33,333 +26666.4%
Value US$10,000
3.5
Gumulka Jerzy Non-Executive Director
Transaction date
Purchase
Price
0.30
Quantity 33,333 +344.6%
Value US$10,000
3.3
Climaco John M Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.30
Quantity 166,666 +340.1%
Value US$50,000
2.3
Downs Christopher Chief Financial Officer Officer
Transaction date
Purchase
Price
1.27
Quantity 27,000 +276.3%
Value US$34,177
3.3
Climaco John M Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.80
Quantity 2,750 +5.9%
Value US$4,944
3.5
Gumulka Jerzy Non-Executive Director
Transaction date
Purchase
Price
1.70
Quantity 2,500 +34.9%
Value US$4,250
2.3
Downs Christopher Chief Financial Officer Officer
Transaction date
Purchase
Price
3.20
Quantity 3,100 +50.4%
Value US$9,920
3.3
Climaco John M Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.69
Quantity 15,000 +50.0%
Value US$10,408
3.5
Gumulka Jerzy Non-Executive Director
Transaction date
Purchase
Price
0.74
Quantity 7,173 +inf%
Value US$5,308
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.04
Quantity 10,000 -6.0%
Value US$10,400
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.09
Quantity 5,000 -2.9%
Value US$5,450
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.08
Quantity 5,000 -2.8%
Value US$5,400
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.08
Quantity 10,000 -5.4%
Value US$10,800
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.08
Quantity 5,000 -2.6%
Value US$5,400
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.10
Quantity 5,000 -2.5%
Value US$5,500
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.08
Quantity 5,000 -2.5%
Value US$5,400
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.13
Quantity 5,000 -2.4%
Value US$5,650
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.24
Quantity 5,000 -2.4%
Value US$6,200
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.22
Quantity 5,000 -2.3%
Value US$6,100
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.35
Quantity 5,000 -2.3%
Value US$6,750
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.30
Quantity 5,000 -2.2%
Value US$6,500
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
1.29
Quantity 5,000 -2.2%
Value US$6,450
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
2.43
Quantity 2,798 -1.2%
Value US$6,799
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
2.40
Quantity 5,500 -2.3%
Value US$13,200
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
2.46
Quantity 5,500 -2.2%
Value US$13,530
1.6
Priebe Waldemar Large shareholder
Transaction date
Sale
Price
2.47
Quantity 5,500 -2.2%
Value US$13,585
2.3
Downs Christopher Chief Financial Officer Officer
Transaction date
Purchase
Price
0.94
Quantity 5,000 +3.4%
Value US$4,702
2.3
Downs Christopher Chief Financial Officer Officer
Transaction date
Purchase
Price
1.15
Quantity 4,500 +3.2%
Value US$5,192
2.3
Downs Christopher Chief Financial Officer Officer
Transaction date
Purchase
Price
2.04
Quantity 142,000 +inf%
Value US$289,680
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-18 2026-05-18 B Purchase
2.2
Fisher Michal
Non-Executive Director
42,290 -5.1%
155.81
US$1,672,331 		42,290 -5.1% 155.81 US$1,672,331
2026-05-20 2026-05-18 B Purchase
3.2
Charles Faith L.
Non-Executive Director
264 -20.3%
60.63
US$2,013,563 		264 -20.3% 60.63 US$2,013,563
2024-02-06 2024-02-01 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
19,380 -3.4%
416.48
US$4,170,183 		19,380 -3.4% 416.48 US$4,170,183
2024-02-06 2024-02-01 B Purchase
Evans Carl Anthony
Non-Executive Director
33,333 +26666.4%
0.30
US$10,000 		33,333 +26666.4% 0.30 US$10,000
2024-02-06 2024-02-01 B Purchase
3.5
Gumulka Jerzy
Non-Executive Director
33,333 +344.6%
0.30
US$10,000 		33,333 +344.6% 0.30 US$10,000
2024-02-06 2024-02-01 B Purchase
3.3
Climaco John M

Chief Executive Officer

Executive Director
166,666 +340.1%
0.30
US$50,000 		166,666 +340.1% 0.30 US$50,000
2023-08-23 2023-08-22 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
27,000 +276.3%
1.27
US$34,177 		27,000 +276.3% 1.27 US$34,177
2023-08-16 2023-08-16 B Purchase
3.3
Climaco John M

Chief Executive Officer

Executive Director
2,750 +5.9%
1.80
US$4,944 		2,750 +5.9% 1.80 US$4,944
2023-04-21 2023-04-19 B Purchase
3.5
Gumulka Jerzy
Non-Executive Director
2,500 +34.9%
1.70
US$4,250 		2,500 +34.9% 1.70 US$4,250
2023-04-18 2023-04-17 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
3,100 +50.4%
3.20
US$9,920 		3,100 +50.4% 3.20 US$9,920
2023-04-14 2023-04-12 B Purchase
3.3
Climaco John M

Chief Executive Officer

Executive Director
15,000 +50.0%
0.69
US$10,408 		15,000 +50.0% 0.69 US$10,408
2023-04-17 2023-04-10 B Purchase
3.5
Gumulka Jerzy
Non-Executive Director
7,173 +inf%
0.74
US$5,308 		7,173 +inf% 0.74 US$5,308
2023-08-01 2023-03-28 S Sale
1.6
Priebe Waldemar
Large shareholder
10,000 -6.0%
1.04
US$10,400 		10,000 -6.0% 1.04 US$10,400
2023-08-01 2023-03-27 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.9%
1.09
US$5,450 		5,000 -2.9% 1.09 US$5,450
2023-08-01 2023-03-24 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.8%
1.08
US$5,400 		5,000 -2.8% 1.08 US$5,400
2023-08-01 2023-03-23 S Sale
1.6
Priebe Waldemar
Large shareholder
10,000 -5.4%
1.08
US$10,800 		10,000 -5.4% 1.08 US$10,800
2023-08-01 2023-03-22 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.6%
1.08
US$5,400 		5,000 -2.6% 1.08 US$5,400
2023-08-01 2023-03-21 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.5%
1.10
US$5,500 		5,000 -2.5% 1.10 US$5,500
2023-08-01 2023-03-20 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.5%
1.08
US$5,400 		5,000 -2.5% 1.08 US$5,400
2023-08-01 2023-03-17 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.4%
1.13
US$5,650 		5,000 -2.4% 1.13 US$5,650
2023-08-01 2023-03-16 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.4%
1.24
US$6,200 		5,000 -2.4% 1.24 US$6,200
2023-08-01 2023-03-15 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.3%
1.22
US$6,100 		5,000 -2.3% 1.22 US$6,100
2023-08-01 2023-03-14 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.3%
1.35
US$6,750 		5,000 -2.3% 1.35 US$6,750
2023-08-01 2023-03-13 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.2%
1.30
US$6,500 		5,000 -2.2% 1.30 US$6,500
2023-08-01 2023-03-10 S Sale
1.6
Priebe Waldemar
Large shareholder
5,000 -2.2%
1.29
US$6,450 		5,000 -2.2% 1.29 US$6,450
2023-08-01 2022-12-09 S Sale
1.6
Priebe Waldemar
Large shareholder
2,798 -1.2%
2.43
US$6,799 		2,798 -1.2% 2.43 US$6,799
2023-08-01 2022-12-08 S Sale
1.6
Priebe Waldemar
Large shareholder
5,500 -2.3%
2.40
US$13,200 		5,500 -2.3% 2.40 US$13,200
2023-08-01 2022-12-07 S Sale
1.6
Priebe Waldemar
Large shareholder
5,500 -2.2%
2.46
US$13,530 		5,500 -2.2% 2.46 US$13,530
2023-08-01 2022-12-06 S Sale
1.6
Priebe Waldemar
Large shareholder
5,500 -2.2%
2.47
US$13,585 		5,500 -2.2% 2.47 US$13,585
2021-12-07 2021-12-06 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
5,000 +3.4%
0.94
US$4,702 		5,000 +3.4% 0.94 US$4,702
2021-11-22 2021-11-19 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
4,500 +3.2%
1.15
US$5,192 		4,500 +3.2% 1.15 US$5,192
2020-08-25 2020-08-24 B Purchase
2.3
Downs Christopher

Chief Financial Officer

Officer
142,000 +inf%
2.04
US$289,680 		142,000 +inf% 2.04 US$289,680
Explore more

More insider trading research around CNS Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America